Industry Press

Here’s the TOP Marijuana Stock You Haven’t Heard Of….YET!

wallstreetnation | Jan 25, 2017

The new year has not only brought the USA a new President, but we’re seeing the next revolution in the Cannabis Market. Marijuana reforms flooded the state legislature and we have seen more than a dozen states loosen laws reflecting the newfound willingness to embrace the trend toward legalization. This is not just in the US, but also our friendly neighbors up North.

Canada Takes Next Step Toward National Marijuana Legalization

Analysts predict Canada could have $4.5 billion industry by 2021; marijuana task force wraps up extensive report that is expected to include recommendations on everything from age limits to medical marijuana, safety and home grows

A legal market for recreational marijuana could give Canada’s economy a boost of up to $22.6 billion annually, says a new study from business services firm Deloitte.

The study estimates that marijuana sales, even initially, would be at least as large as hard liquor sales in Canada, at around $5 billion annually, but could be as large as $8.7 billion, making them as large as wine sales.

Bloomberg reports that Canada will become the First G7 Nation to Fully Legalize Weed this Year.

Check out the video below:

Marapharm Ventures Inc. (OTC QB: MRPHF) is a truly remarkable opportunity. The company has applied to Health Canada to become a licensed producer under the Marijuana for Medical Purposes Regulations (MMPR) issued pursuant to the Controlled Drugs and Substances Act (Canada). The application is currently in the in-depth screening process.

In September 2016, Health Canada contacted Marapharm with a provision to amend its application to allow for the new regulations, ACMPR.

Marapharm’s initial facility, a proposed 22,000 square foot state-of-the-art designed-to-suit cultivation facility, will be constructed on an 11 acre leased site in Kelowna, British Columbia.

MRPHFs growth strategy will be to build facilities or acquire licenses in the United States, determined by identifying opportunities and researching the direction and location of sales. The company has currently focused its attention on opportunities in Nevada and Washington.

MRPHF Is More Than Just A Cannabis Opportunity; They own Real Estate, Health and Wellness Supplements, and Retail Dispensaries

MRPHF has purchased Land in North Las Vegas, Nevada, for purposes of building a cultivation and production facility that will house three medical marijuana licenses. Construction has already begun.

MRPHF has also purchased and is developing an all-natural hemp oil product line called, Maragold, which will be ready for market within a few months.

Such impressive growth fosters the need for a strategically aligned partner. Look no further than the past few weeks. Wall Street may have missed this but we certainly did not.

BREAKING NEWS: MRPHF has invested heavily into Veritas Pharma IncVeritas Pharma Inc, a company which aims to develop the most effective proprietary cannabis strains for specific disease conditions, and to provide doctors and patients with conclusive scientific evidence to recommend and use medical marijuana with confidence, advancing the science behind medical marijuana.

Marijuana Is Officially Legal In Nevada, California and Washington State

As of New Years 2017, What happens in Vegas doesn’t always stay in Vegas.

Marapharm has a growing footprint in the US Market is expanding the business model to include “vertical plus” farming in its Nevada and Washington marijuana facilities.

California Dreamin’

Marapharm is also expanding into California. On November 16, the company entered into an an agreement to purchase an industrial facility in southern California and three medical marijuana licenses for manufacturing, cultivation, and retail uses. The land size is 40,510 square feet and the existing building size is 6,875 square feet, with a 19-foot-ceiling clearance, for a purchase price of $3.2 million based on $450 per square foot for the building and $65 per square foot for the land. The yard area is paved and suitable for greenhouse growing.

Marapharm also has automated cannabis machines, which will be located within retail outlets or dispensaries in Washington and Nevada. ACMs will stock and only sell Marapharm products in states where Marapharm owns the cultivation facilities and is permitted to act as a retail dispenser. In other areas, the machines will be leased to growers or will occupy floor space in retail outlets and dispensaries under revenue participation agreements.

Beyond the Numbers: The Stats tell the Tale

Statistics – Medical Marijuana Canada

Health Canada states that there are 40,000 registered medical marijuana patients. In a separate Government of Canada survey on drug and alcohol use, of all those questioned on the use of marijuana, 420,000 admitted that they use marijuana for a medical reason.
At 1 ounce per month average cost $200 per ounce, this amounts to $84 million per year!

Statistics – Recreational Marijuana Canada

12.2% of Canadians use marijuana. The Canadian population is 35,154,300. There are 4,288,824 marijuana users in Canada.

Statistics – Medical Marijuana United States

Estimated 2,434,192 patients use medical marijuana in the U.S. Calculated at a possible $200 per month patient use: $ 5.8 Billion US

Statistics – Recreational Marijuana United States

19.8 million users in the U.S. in the past month ( An article in the Washington Post quotes a report by Greenwave Advisors estimating, if legalized, the U.S. marijuana industry could be worth $35 Billion by 2020. To put that into perspective: The NFL is worth $10 Billion. The whole U.S. confectionary market is worth $34 Billion.

Statistics – Recreational Marijuana Worldwide

There are an estimated 180.6 million marijuana users worldwide. The worldwide black market is estimated at $141.80 Billion.

Statistics – Opinions

In Canada 66% of those polled feel marijuana should be legalized and taxed
In the U.S. 88% of those polled feel Medical Marijuana should be legal, 58% support legalization and taxation.

Given the strong numbers, it’s hardly surprising that many believe cannabis is the one of the hottest sectors for investors in 2017 and beyond.

Why Lawmakers Want to Legalize Marijuana’s Cousin

Marijuana legalization is still a contentious issue in Congress that few politicians have been willing to get behind.

But when it comes to hemp — a close relative in the cannabis family — a bipartisan effort to deregulate the plant is moving forward.


Hemp has been used in healing for centuries but faced an almost world-wide ban for a large part of the twentieth century and into the early part of the 21st century. In recent years the ban is gradually being lifted and this wonder-working, broad spectrum plant is now being made available for its many therapeutic uses.

A subsidiary, Maragold health and wellness products, is a line of all natural products blended with hemp and made up of raw essential oils and natural ingredients.

Why Investors Should Move On Undervalued Opportunities Now

It’s safe to say that government intervention in the marijuana space is positive all around for investors. Once Wall Street discovers Marapharm Ventures Inc. (OTC QB: MRPHF), the demand should be off-the-charts.

Currently trading with a market cap of under $60 Million, MRPHF has a ton going for it with a substantial jump on its competitors.

With so many potential revenue streams, investors should, at the very least start their research on this company before it potentially takes off.

MRPHF looks to be one of the must-own stocks in the cannabis space.


| 2M0 (zero) on FSE: